Quick answers
- What is Bacteriostatic Sodium Chloride?
- Bacteriostatic Sodium Chloride is a brand name of Sodium chloride, a prescription medicine. The FDA NDC Directory lists 7 Bacteriostatic Sodium Chloride products in 2 strengths and forms.
- Who makes Bacteriostatic Sodium Chloride?
- Hospira holds the FDA application for Bacteriostatic Sodium Chloride (NDA018800, approved October 29, 1982). 5 other companies (repackagers or distributors) also list Bacteriostatic Sodium Chloride products.
- Is there a generic or store brand of Bacteriostatic Sodium Chloride?
- Yes. The FDA NDC Directory lists 37 other products with the same active ingredients, strength and form as a Bacteriostatic Sodium Chloride product, 25 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Bacteriostatic Sodium Chloride?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 Bacteriostatic Sodium Chloride strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Bacteriostatic Sodium Chloride been recalled?
- No recall linked to Bacteriostatic Sodium Chloride products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Bacteriostatic Sodium Chloride is
Each Bacteriostatic Sodium Chloride product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Sodium chloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| sodium chloride 9 mg/mL injection (intramuscular, intravenous, subcutaneous) | Bacteriostatic Sodium Chloride | 7 products, 6 companies | DailyMed |
| sodium chloride 9 mg/mL injection, solution (intramuscular, intravenous, subcutaneous) | Bacteriostatic Sodium Chloride | 30 products, 12 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Sodium chloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA018800 | Hospira | October 29, 1982 | 6 |
| ANDA088911 | Fresenius Kabi USA | February 7, 1985 | 1 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| sodium chloride 9 mg/mL injection, solution | Generic: Bacteriostatic Sodium Chloride | $0.0699 per mL Generic of the same strength and form: $0.0699–$0.0915 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Bacteriostatic Sodium Chloride
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Bacteriostatic Sodium Chloride products.
- HF Acquisition Co LLC, DBA HealthFirst2 products
- Medical Purchasing Solutions, LLC1 product
- Henry Schein, Inc.1 product
- ProPharma Distribution1 product
- Hospira, Inc.1 product
- Fresenius Kabi USA, LLC1 product
Recalls
No recall linked to Bacteriostatic Sodium Chloride products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.